Average Co-Inventor Count = 5.97
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (12 from 212 patents)
2. Merck Frosst Canada & Co. (7 from 80 patents)
3. Merck + Co., Inc. (2 from 4,770 patents)
4. Merck Canada Inc. (2 from 40 patents)
5. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
6. Actelion Pharmaceuticals Ltd (1 from 217 patents)
7. Merck Forsst Canada & Co. (1 from 1 patent)
8. Idorsia Pharmaceuticals Ltd (77 patents)
26 patents:
1. 8889714 - 3,4-substituted piperidine derivatives as renin inhibitors
2. 8076359 - Renin inhibitors
3. 8063105 - Renin inhibitors
4. 7960409 - Pharmaceutical phenylquinoline and chromen-2-one triazole compounds
5. 7553973 - Pharmaceutical compounds
6. 7439260 - 7-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
7. 6699856 - Pyrazinones, compositions containing such compounds and methods of use
8. 6552168 - Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
9. 6525025 - Gamma-ketoacid dipeptides as inhibitors of caspase-3
10. 6444811 - Pyrazinones, compositions containing such compounds and methods of use
11. 6225288 - Gamma-ketoacid dipeptides as inhibitors of caspase-3
12. 6222048 - Diaryl-2-(5H)-furanones as Cox-2 inhibitors
13. 6169188 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors
14. 6133292 - Diaryl-5-alkyl-5-methyl-2-(5H)-furanones as selective
15. 6071954 - (methylsulfonyl)phenyl-2-(5H)-furanones with oxygen link as COX-2